In the news:
Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook
Acurx Pharmaceuticals
Save
ShareKey facts
- city: Staten Island
- state: NY
- country: United States
- sector: Health Care
- industry: Biotechnology
- CEO: David P. Luci CPA, CPA, Esq., J.D.
Classified as: organization
Summary
Acurx Pharmaceuticals is a company. It is located in Staten Island, the United States. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Business
Acurx Pharmaceuticals is one of the companies in the United States, companies in Biotechnology, companies in Health Care and 3,466,499 companies in our database.
- Assets: 13.3M $
- Debt: 0.00 $
- Employees: 3 people
- Free cash flow: -3243160 $
- Market cap: 38.6M $
- Revenues:
get
Premium to see estimate
Stocks from Acurx Pharmaceuticals
Explore more on business
Talking Points:
- Acurx Pharmaceuticals, Inc.
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Learn more about talking points